<TEXT>&#2;<DATELINE>2011-07-18</DATELINE><TITLE>A review of bronchiolitis obliterans syndrome and therapeutic strategies</TITLE><BODY>Lung transplantation is an important treatment option for patients with advanced lung disease. Survival rates for lung transplant recipients have improved; however, the major obstacle limiting better survival is bronchiolitis obliterans syndrome (BOS). In the last decade, survival after lung retransplantation has improved for transplant recipients with BOS. This manuscript reviews BOS along with the current therapeutic strategies, including recent outcomes for lung retransplantation.&#3;</BODY></TEXT>